Details of issuance or disposal
Report on the large-scale exercise and monthly exercise status of the 6th Series Stock Acquisition Rights, the 1st Series Unsecured Convertible Bonds with Stock Acquisition Rights, and the 7th Series Stock Acquisition Rights with Exercise Price Adjustment Clauses, issued through a private placement to a third party
Sixth Series Stock Acquisition Rights 130,000 shares (new shares) / 7th Series stock acquisition rights 211,000 shares (new shares)
11.72% (341,000 shares delivered for all series combined / 2,911,799 listed shares outstanding as of the issue and payment date)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the large-scale exercise and monthly exercise status of the 6th Series Stock Acquisition Rights, the 1st Series Unsecured Convertible Bonds with Stock Acquisition Rights, and the 7th Series Stock Acquisition Rights with Exercise Price Adjustment Clauses, issued through a private placement to a third party |
| Number of shares to be issued or disposed of | Sixth Series Stock Acquisition Rights 130,000 shares (new shares) / 7th Series stock acquisition rights 211,000 shares (new shares) |
| Intended allottee | GP上場企業出資投資事業有限責任組合 (former allottee) |
| Dilution Rate | 11.72% (341,000 shares delivered for all series combined / 2,911,799 listed shares outstanding as of the issue and payment date) |
| Total number of issued shares | 2,998,499 shares (as of the end of the month preceding the target month, including 3,329 treasury shares) → Not disclosed |
| Exercise price | ¥432 for the 6th Series Stock Acquisition Rights. The 7th Series Stock Acquisition Rights had exercise prices of ¥164, ¥166, ¥165, ¥209, ¥281, ¥373, ¥319, ¥363, ¥294, ¥272, ¥245, and others. Details of the adjustment clauses and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued 6th Series: 13,900 rights; 7th Series: 20,050 rights (total issuance calculated from the stated monthly exercise ratios) / Unexercised balance 6th Series: 8,288 rights; 7th Series: 17,074 rights (as of the end of July 2026) |
| Procedures under the Corporate Code of Conduct | Disclosure of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Issued on 14 April 2025: the 6th Series Stock Acquisition Rights and the 1st Series Unsecured Convertible Bonds with Stock Acquisition Rights (issue amount: Not disclosed), Issued on 15 June 2026: the 7th Series Stock Acquisition Rights with Exercise Price Adjustment Clauses (issue amount: Not disclosed) |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.All exercises of the 6th Series Stock Acquisition Rights and some exercises of the 7th Series Stock Acquisition Rights became exercisable beyond the exercise restriction because their exercise prices were at or above the closing price as of the time the issuance of the 7th Series Stock Acquisition Rights was approved.